Search research articles
Contact Us
Filters
Showing results (91-100 of 111) with videos related to
Page
of 12
Sort By:
Blood
|
August 12, 2022
Pretransplant FLT3-ITD MRD assessed by high-sensitivity PCR-NGS determines posttransplant clinical outcome
Sun Loo, Richard Dillon, Adam Ivey, et al.
Blood
|
November 6, 2024
Acute promyelocytic leukemia: long-term outcomes from the HARMONY project
Maria Teresa Voso, Luca Guarnera, Söhren Lehmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 18, 2024
Treatment Intensification With Either Fludarabine, AraC, G-CSF and Idarubicin, or Cladribine Plus Daunorubicin and AraC on the Basis of Residual Disease Status in Older Patients With AML: Results From the NCRI AML18 Trial
Nigel H Russell, Abin Thomas, Robert K Hills, et al.
Blood
|
August 6, 2025
Induction chemotherapy and molecular MRD influence outcomes in KMT2A-rearranged AML
Jad Othman, Nicola Potter, Sylvie D Freeman, et al.
The Lancet. Haematology
|
April 30, 2025
Molecular monitoring versus standard clinical care in younger adults with acute myeloid leukaemia: results from the UK NCRI AML17 and AML19 randomised, controlled, phase 3 trials
Nicola Potter, Jelena Jovanovic, Adam Ivey, et al.
Blood
|
August 18, 2023
Fractionated vs single-dose gemtuzumab ozogamicin with determinants of benefit in older patients with AML: the UK NCRI AML18 trial
Sylvie D Freeman, Abin Thomas, Ian Thomas, et al.
Pharmacotherapy
|
June 10, 2024
Consensus recommendations for the use of novel antiretrovirals in persons with HIV who are heavily treatment-experienced and/or have multidrug-resistant HIV-1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy
David B Cluck, Daniel B Chastain, Milena Murray, et al.
Pharmacotherapy
|
June 10, 2024
Consensus recommendations for the use of novel antiretrovirals in persons with HIV who are heavily treatment-experienced and/or have multidrug-resistant HIV-1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy: An executive summary
David B Cluck, Daniel B Chastain, Milena Murray, et al.
Transplantation Direct
|
September 13, 2021
Clinical Practice Guideline for Solid Organ Donation and Transplantation During the COVID-19 Pandemic
Matthew J Weiss, Laura Hornby, Farid Foroutan, et al.
Pulmonary Circulation
|
May 31, 2019
EXPRESS: Acute Vasoreactivity Testing in Pediatric Idiopathic Pulmonary Arterial Hypertension: an international Survey on Current Practice
Lina Caicedo, Rachel K Hopper, Humberto Garcia, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 111) with videos related to
Sort By:
Page
of 12
Blood
|
August 12, 2022
Pretransplant FLT3-ITD MRD assessed by high-sensitivity PCR-NGS determines posttransplant clinical outcome
Sun Loo, Richard Dillon, Adam Ivey, et al.
Blood
|
November 6, 2024
Acute promyelocytic leukemia: long-term outcomes from the HARMONY project
Maria Teresa Voso, Luca Guarnera, Söhren Lehmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 18, 2024
Treatment Intensification With Either Fludarabine, AraC, G-CSF and Idarubicin, or Cladribine Plus Daunorubicin and AraC on the Basis of Residual Disease Status in Older Patients With AML: Results From the NCRI AML18 Trial
Nigel H Russell, Abin Thomas, Robert K Hills, et al.
Blood
|
August 6, 2025
Induction chemotherapy and molecular MRD influence outcomes in KMT2A-rearranged AML
Jad Othman, Nicola Potter, Sylvie D Freeman, et al.
The Lancet. Haematology
|
April 30, 2025
Molecular monitoring versus standard clinical care in younger adults with acute myeloid leukaemia: results from the UK NCRI AML17 and AML19 randomised, controlled, phase 3 trials
Nicola Potter, Jelena Jovanovic, Adam Ivey, et al.
Blood
|
August 18, 2023
Fractionated vs single-dose gemtuzumab ozogamicin with determinants of benefit in older patients with AML: the UK NCRI AML18 trial
Sylvie D Freeman, Abin Thomas, Ian Thomas, et al.
Pharmacotherapy
|
June 10, 2024
Consensus recommendations for the use of novel antiretrovirals in persons with HIV who are heavily treatment-experienced and/or have multidrug-resistant HIV-1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy
David B Cluck, Daniel B Chastain, Milena Murray, et al.
Pharmacotherapy
|
June 10, 2024
Consensus recommendations for the use of novel antiretrovirals in persons with HIV who are heavily treatment-experienced and/or have multidrug-resistant HIV-1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy: An executive summary
David B Cluck, Daniel B Chastain, Milena Murray, et al.
Transplantation Direct
|
September 13, 2021
Clinical Practice Guideline for Solid Organ Donation and Transplantation During the COVID-19 Pandemic
Matthew J Weiss, Laura Hornby, Farid Foroutan, et al.
Pulmonary Circulation
|
May 31, 2019
EXPRESS: Acute Vasoreactivity Testing in Pediatric Idiopathic Pulmonary Arterial Hypertension: an international Survey on Current Practice
Lina Caicedo, Rachel K Hopper, Humberto Garcia, et al.
Page
of 12